Phathom Pharmaceuticals, Inc (PHAT)

followers · Follow

Sector:	HEALTH CARE
Industry:	PHARMACEUTICALS
SIC:	PHARMACEUTICAL PREPARATIONS
CEO:	Terrie Curran
Employees:	110
Web site:	phathompharma.com
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932 (877) 742-8466

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

Phathom Pharmaceuticals, Inc. focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach.

Please log in first to see chart

Phathom Pharmaceuticals, Inc YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available